News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
872,885 Results
Type
Article (88159)
Company Profile (825)
Press Release (783882)
Multimedia
Podcasts (206)
Webinars (30)
Section
Business (233343)
Career Advice (4152)
Deals (39895)
Drug Delivery (155)
Drug Development (91473)
Employer Resources (205)
FDA (18426)
Job Trends (17439)
News (398105)
Policy (39991)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (38)
Adcomms (36)
Allergies (161)
Alliances (56982)
ALS (189)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (371)
Approvals (18623)
Artificial intelligence (673)
Autoimmune disease (188)
Automation (47)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (171)
Brain cancer (68)
Breast cancer (692)
Cancer (5289)
Cardiovascular disease (469)
Career advice (3577)
Career pathing (43)
CAR-T (317)
CDC (66)
Celiac Disease (2)
Cell therapy (870)
Cervical cancer (39)
Clinical research (77343)
Collaboration (1932)
Company closure (5)
Compensation (1221)
Complete response letters (79)
COVID-19 (3002)
CRISPR (106)
C-suite (955)
Cystic fibrosis (155)
Data (6601)
Decentralized trials (2)
Denatured (76)
Depression (160)
Diabetes (553)
Diagnostics (7312)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (328)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (256)
Earnings (100650)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135735)
Executive appointments (1068)
FDA (21772)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1629)
Gene editing (229)
Generative AI (71)
Gene therapy (710)
GLP-1 (1164)
Government (5475)
Grass and pollen (8)
Guidances (389)
Healthcare (20978)
HIV (76)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (308)
Immuno-oncology (74)
Indications (126)
Infectious disease (3319)
Inflammatory bowel disease (216)
Inflation Reduction Act (17)
Influenza (133)
Intellectual property (268)
Interviews (817)
IPO (17969)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (72)
Kidney cancer (20)
Labor market (98)
Layoffs (662)
Leadership (43)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (712)
Lymphoma (394)
Machine learning (46)
Management (66)
Manufacturing (914)
MASH (180)
Medical device (15086)
Medtech (15150)
Mergers & acquisitions (23030)
Metabolic disorders (1467)
mRNA (200)
Multiple sclerosis (176)
NASH (23)
Neurodegenerative disease (381)
Neuropsychiatric disorders (108)
Neuroscience (3233)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5120)
Now hiring (70)
Obesity (716)
Opinion (347)
Ovarian cancer (173)
Pain (226)
Pancreatic cancer (249)
Parkinson's disease (316)
Partnered (39)
Patents (544)
Patient recruitment (545)
Peanut (64)
People (67126)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23901)
Phase 2 (33561)
Phase 3 (25276)
Pipeline (5912)
Policy (355)
Postmarket research (3554)
Preclinical (10721)
Press Release (72)
Prostate cancer (268)
Psychedelics (60)
Radiopharmaceuticals (316)
Rare diseases (992)
Real estate (7444)
Recruiting (81)
Regulatory (29303)
Reports (69)
Research institute (2740)
Resumes & cover letters (653)
Rett syndrome (29)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (273)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (28)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (116)
Tariffs (101)
The Weekly (128)
Vaccines (1188)
Venture capital (101)
Weight loss (493)
Women's health (103)
Worklife (23)
Date
Today (252)
Last 7 days (914)
Last 30 days (3084)
Last 365 days (32825)
2026 (5198)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (354)
Arkansas (15)
Asia (51674)
Australia (9078)
California (12106)
Canada (3449)
China (1221)
Colorado (511)
Connecticut (526)
Delaware (360)
Europe (118877)
Florida (1798)
Georgia (391)
Hawaii (4)
Idaho (68)
Illinois (1009)
India (79)
Indiana (569)
Iowa (24)
Japan (461)
Kansas (135)
Kentucky (46)
Louisiana (31)
Maine (84)
Maryland (1506)
Massachusetts (8876)
Michigan (378)
Minnesota (682)
Mississippi (7)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (132)
New Hampshire (88)
New Jersey (3246)
New Mexico (33)
New York (3187)
North Carolina (1671)
North Dakota (10)
Northern California (5856)
Ohio (375)
Oklahoma (23)
Oregon (55)
Pennsylvania (2413)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4681)
Tennessee (185)
Texas (1903)
United States (43552)
Utah (367)
Vermont (1)
Virginia (306)
Washington D.C. (88)
Washington State (1005)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 872,885 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GEMMABio Announces First Patient Dosed in CHARISMA Trial of GB221, Investigational Next‑Generation Gene Therapy for Spinal Muscular Atrophy Type 1 (SMA1)
February 26, 2026
·
5 min read
Press Releases
Transformative Biotech Names Mark Kelleher, PhD as Executive VP of R&D
February 26, 2026
·
2 min read
Press Releases
Curium Announces Pharmacokinetics and Dosimetry Data for Investigational Lutetium-177 Zadavotide Guraxetan in Metastatic Castration-Resistant Prostate Cancer at ASCO GU 2026
February 26, 2026
·
3 min read
Press Releases
Ketryx Enters 2026 with Record Momentum as Demand for Validated AI Surges
February 26, 2026
·
1 min read
Press Releases
Vocxi Health and Forj Medical Partner to Miniaturize Breath-Based Cancer Detection Device Platform
Advanced engineering collaboration accelerates development of MyBreathPrint™, a revolutionary Class II medical device platform that detects lung cancer and other diseases from a single minute of breathing
February 26, 2026
·
1 min read
Layoff Tracker
Viatris Will Cut Up to 10% of Global Workforce Over 3 Years
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
February 26, 2026
·
58 min read
·
BioSpace Editorial Staff
Earnings
After Sarepta’s Annus Horribilis, Elevidys Sales Expected To Continue Downward Spiral
After a rocky 2025, Sarepta Therapeutics’ executives admit they have work to do to bring patients back into the fold as sales of Duchenne muscular dystrophy gene therapy Elevidys continue to decline.
February 26, 2026
·
5 min read
·
Annalee Armstrong
FDA
FDA’s One Trial Policy Not a Revolution but a Potentially Risky Evolution
Last week, the FDA made its one pivotal trial policy official, sparking myriad questions from industry leaders, including around specific evidence required for the single study and why it hasn’t been implemented across all therapeutic areas before now.
February 26, 2026
·
7 min read
·
Heather McKenzie
Press Releases
Optimi Health Reports Early Clinical Rollout of Natural Psilocybin Capsules for Treatment-Resistant Depression in Australia
First Patients of 2026 Treated Outside of Sponsor-Led Clinical Trials Under Australia’s Regulated Framework
February 26, 2026
·
5 min read
Press Releases
NeuraLight at AD/PD 2026: Revealing Next-Generation Brain-Function Biomarker Readouts Powering a First-of-its-Kind Neuroprotection Signal in Drug Trials
February 26, 2026
·
2 min read
1 of 87,289
Next
